The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump, Robert Cyran of Reuters Breakingviews writes.Samuel Waksal’s new biotechnology company tests Wall Street’s selective amnesia. Mr. Waksal, the former ImClone boss who went to prison for an insider trading scandal that also ensnared Martha Stewart, said on Wednesday that he planned to take his latest venture, Kadmon, public this year. He follows others who have been given second chances like Donald Trump and John Meriwether, the founder of Long-Term Capital Management. Investors can be astonishingly forgiving.The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump, Robert Cyran of Reuters Breakingviews writes.